Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Maria LeeJinlan PiaoMyung Jae JeonPublished in: Yonsei medical journal (2020)
In premenopausal BC patients treated with tamoxifen, abnormal uterine bleeding, increased endometrial thickness, and chemotherapy for BC were associated with the occurrence of endometrial cancer. These findings may provide useful information for gynecologic surveillance and counseling during tamoxifen treatment in premenopausal BC patients.
Keyphrases
- endometrial cancer
- postmenopausal women
- end stage renal disease
- breast cancer cells
- estrogen receptor
- positive breast cancer
- breast cancer risk
- ejection fraction
- newly diagnosed
- chronic kidney disease
- public health
- peritoneal dialysis
- early breast cancer
- atrial fibrillation
- prognostic factors
- squamous cell carcinoma
- smoking cessation
- locally advanced
- young adults
- health information
- replacement therapy
- patient reported outcomes
- human immunodeficiency virus
- antiretroviral therapy
- rectal cancer